Search News
-
AbbVie and Pfizer lead rheumatoid arthritis digital marketing space in Australia
Australia | Analysis | 0 Comment
Rheumatoid arthritis (RA) treatment landscape in Australia is well established with several novel disease-modifying anti...Read more
-
AbbVie pips Gilead to dominate Japan’s hepatitis C virus digital marketing space
Japan | News | 0 Comment
The hepatitis C virus (HCV) therapeutics market in Japan is highly competitive with stiff competition between Gilead and...Read more
-
Harbour BioMed licenses SARS-CoV-2 neutralizing Ab to AbbVie for COVID-19 treatment
Therapeutics | News | 0 Comment
China based Harbour BioMed and Utrecht University in the Netherlands have announced that they licensed to American firm ...Read more
-
AbbVie, Genmab enter $4B cancer immunotherapy partnership
Japan | News | 0 Comment
US-based AbbVie and Genmab announced on 10 June 2020 that they had formed the partnership that will focus on b...Read more
-
AbbVie, Harbour BioMed to develop Ab therapy for COVID-19
COVID19 | News | 0 Comment
US based company AbbVie, Harbour BioMed (HBM) with operations in US and China, Utrecht University (UU) in Europe and Era...Read more
-
AbbVie receives FDA approval for RINVOQ
Pharma | News | 0 Comment
AbbVie, a research-based global biopharmaceutical company, has announced that the U.S. Food and Drug Administratio...Read more
-
Abbvie to acquire Allergan in a deal worth $63B
Pharma | News | 0 Comment
AbbVie and Allergan have announced that the companies have entered into a definitive transaction agreement und...Read more
-
NHS England partners with Gilead, Merck & AbbVie to eliminate Hep C
Healthcare | News | 1 Comment
The NHS will find and cure tens of thousands more people with hepatitis C as part of a ground-breaking deal that could h...Read more
-
AbbVie expands immunology portfolio in the U.S. with FDA approval of SKYRIZI™
World | News | 0 Comment
AbbVie , a research-based global biopharmaceutical company has announced that the U.S. Food and Drug Administration (FDA...Read more
-
AbbVie gets the first global regulatory approval of SKYRIZI in Japan
BioServices | News | 0 Comment
AbbVie, a research-based global biopharmaceutical company, has announced that the Japanese Ministry of Health, Labour an...Read more
